CAS No. |
132210-34-5 |
中文名称 |
13-甲基-[1,3]二氧杂环戊烯并[4',5':4,5]苯并[1,2-c][1,3]二氧杂环戊烯并[4,5-i]菲蒽啶-13-鎓(2R,3S,4R,5R)-2,3,4,5,6-五羟基己酸盐 |
英文名称 |
13-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate |
别名 |
Sanguinarine citrate;product/153315;Sanguinarine (gluconate);Sanguirine citrate |
标准英文名 |
13-methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate |
分子式 |
C26H25NO11 |
分子量 |
527.48
|
精确分子量 |
527.14
|
SMILES |
C[N+]1=C2C3=CC4=C(C=C3C=CC2=C2C=CC3=C(OCO3)C2=C1)OCO4.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
标准SMILES |
C[N+]1C=C2C3OCOC=3C=CC2=C2C=CC3=CC4OCOC=4C=C3C=12.[O-]C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
用途 |
Potential clinical application as an anticancer agent due to its ability to effectively downregulate CIP2A protein and inhibit cancer cell proliferation, with advantages including low toxicity, significant antiproliferative effects, broad-spectrum anticancer activity, ease of preparation, and low cost; used as an intermediate in pharmaceutical and chemical synthesis, particularly in the formulation of combination Western medicines for the treatment of pertussis; employed in content determination, compound identification, and pharmacological experiments. |
InChIKey |
LUQSYLIFPGNCMW-IFWQJVLJSA-M |